SCHEMBL13437804

SCHEMBL13437804

CNc1cc(C)nc(C(C)C)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.52
NOS2 P35228 1/20 0.52
ALOX15 P16050 1/20 0.43
ALDH1A1 P00352 5/20 0.41
TP53 P04637 2/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
ACHE P22303 1/20 0.41
HSD17B10 Q99714 1/20 0.41
RAB9A P51151 1/20 0.35
GBA1 P04062 1/20 0.34
NUDT1 P36639 3/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
LMNA P02545 1/20 0.32
AURKA O14965 1/20 0.31
AURKB Q96GD4 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL801826 0.82 TRPM8 (0.42) NOS3NOS2ALDH1A1TP53CYP3A4
SCHEMBL2625460 0.79 ALDH1A1 (0.46) NOS3NOS2ALDH1A1TP53CYP3A4
SCHEMBL20919369 0.78 HRH4 (0.43) NOS3NOS2NUDT1
SCHEMBL13485708 0.75 NOS3 (0.57) NOS3NOS2ALOX15ALDH1A1TP53
SCHEMBL13309905 0.74 ALDH1A1 (0.39) ALOX15ALDH1A1TP53CYP3A4TSHR
SCHEMBL4915813 0.73 NOS3 (0.60) NOS3NOS2ALOX15ALDH1A1TP53
SCHEMBL17303780 0.72 CCNT1 (0.40) ALDH1A1TP53CYP3A4TSHRACHE
SCHEMBL12411159 0.72 NOS3 (0.48) NOS3NOS2ALOX15ALDH1A1NUDT1
SCHEMBL12499637 0.71 NOS3 (0.58) NOS3NOS2ALOX15ALDH1A1CYP3A4
SCHEMBL10167712 0.71 NOS3 (0.43) NOS3NOS2ALDH1A1TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015091584-A1 THIAZOLOPYRIDINE COMPOUNDS, COMPOSITIONS AND THEIR USE AS TYK2 KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2015-06-25 WO disclosed
US-7691853-B2 Pyrazole compounds useful as protein kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-04-06 US disclosed
US-20090269379-A1 Material Having Antibacterial and Antifungal Properties CIBA CORP. 2009-10-29 US disclosed
US-20070270444-A1 Pyrazole compounds useful as protein kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED 2007-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270444-A1 Pyrazole compounds useful as protein kinase inhibitors GSK3B, CDK3, GSK3A NOS3 715/4885NOS2 1597/4885ALOX15 3848/4885
US-20090269379-A1 Material Having Antibacterial and Antifungal Properties POLR1C, NISCH, HSPH1 NOS3 269/4885NOS2 530/4885ALOX15 2322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.